Inventor profile of:

Shenda Baker

City:

Upland, California

Country:

United States

Published Applications:

18

Last publication date:

2022-05-26

Top Assignees for applications by Shenda Baker

The entities that hold a legal rights for patent applications filed by inventor Baker Shenda:

Recent patent applications by Baker Shenda

Shenda Baker from Upland, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-26
US20220160754A1
Human necessities

Derivatized chitosan polymers and methods of treating vascular disorders

#2 | 2018-08-23
US20180235998A1
Human necessities

Derivatized chitosan polymers and methods of treating vascular disorders

#3 | 2017-10-26
US20170304355A1
Human necessities

COMPOSITIONS AND METHODS OF USE THEREOF

#4 | 2017-05-18
US20170136056A1
Human necessities

METHODS AND COMPOSITIONS FOR DISRUPTING BIOFILM UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS

#5 | 2017-05-04
US20170119810A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS

#6 | 2016-03-03
US20160060362A1
Chemistry; metallurgy

Chitosan-derivative compounds and methods of controlling microbial populations

#7 | 2016-01-28
US20160022564A1
Human necessities

ORAL FORMULATION OF POLYGLUCOSAMINE DERIVATIVES IN COMBINATION WITH A NON-FERMENTABLE SUGAR

#8 | 2014-08-07
US20140221308A1
Human necessities

METHODS AND COMPOSITIONS OF REDUCING AND PREVENTING BACTERIAL GROWTH AND THE FORMATION OF BIOFILM ON A SURFACE UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS

#9 | 2013-08-15
US20130210761A1
Human necessities

Methods and compositions for treating wounds utilizing chitosan compounds

#10 | 2012-12-27
US20120329753A1
Chemistry; metallurgy

Chitosan-derivative compounds and methods of controlling microbial populations

#11 | 2012-12-27
US20120329751A1
Human necessities

METHODS AND COMPOSITIONS FOR DISRUPTING BIOFILM UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS

#12 | 2012-11-29
US20120301408A1
Human necessities

ORAL CARE METHODS AND COMPOSITIONS UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS

#13 | 2012-11-22
US20120295355A1
Human necessities

NUCLEIC ACID DELIVERY USING MODIFIED CHITOSANS

#14 | 2010-06-03
US20100137193A1
Chemistry; metallurgy

Chitosan derivatives to treat animals or optimize animal health

#15 | 2010-05-27
US20100130443A1
Human necessities

Chitosan derivatives, compositions and related methods of use

#16 | 2010-03-04
US20100056474A1
Human necessities

Methods and compositions for the prevention of and treatment of infections utilizing chitosan-derivative compounds

#17 | 2008-10-09
US20080248508A1
Chemistry; metallurgy

Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials

#18 | 2007-12-06
US20070281904A1
Chemistry; metallurgy

Chitosan-derivative compounds and methods of controlling microbial populations

InventorID:

391046 ⎘